Averitas Pharma
UEI: U5RSG4BNQFQ8
Overview
Awardee Type
Parent
(1 child)
Name
Averitas Pharma
Headquarters
Morristown, NJ
United States
United States
Federal recipient
AVERITAS PHARMA, INC
(UEI U5RSG4BNQFQ8)
is headquartered in Morristown NJ.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in July 2018 and
federally registered in
August 2018.
Federal Registration and Certifications
This Parent entity does not have an associated active registration. Showing registration information for UEI QU48MTF1KBT5 CAGE 85WE5 instead.
Legal Name
AVERITAS PHARMA, INC
Division Name
AVERITAS PHARMA, INC.
UEI
QU48MTF1KBT5
CAGE Code
85WE5
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
July 16, 2018
Initial Registration
Aug. 6, 2018
Last Registration
July 4, 2024
Registration Activation
July 3, 2024
Registration Expiration
July 1, 2025
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
Manufacturer of Goods
For Profit Organization
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Accepts Credit Cards
No
People
Vendor contacts at Averitas Pharma
GSA Schedules and Price Lists
- Averitas Pharma
- PoP: 4/30/19 - 1/31/26
- Type: Pharmaceuticals and Drugs (FSS 65 I B)